This is filed for the patient adverse events: it was reported through a research article identifying the absorb bioresorbable vascular scaffold (bvs) that may be related to: death, thrombosis, stenosis, myocardial infarction, revascularization, hospitalization and treatment with medication.Specific patient information is documented as unknown.Details are listed in the attached article, titled: "hybrid-stenting with metallic and bioresorbable drug-eluting stents 2-year clinical outcomes in (b)(6) registry.".
|
The devices remain implanted and were not returned for analysis.A review of the lot history records and complaint histories could not be conducted because the lot and part numbers were not provided.The reported patient effects of thrombosis, myocardial infarction and stenosis are listed and consistent with the product risk profile and are therefore expected.A conclusive cause for the difficulties listed can not be determined based on the limited information available.The patient effects listed are consistent with the product risk profile and are therefore expected.Based on the information reviewed, there is no indication of a product quality issue with respect to manufacture, design or labeling.
|